|
AU740916B2
(en)
*
|
1996-10-28 |
2001-11-15 |
University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
|
US6887707B2
(en)
*
|
1996-10-28 |
2005-05-03 |
University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
|
US6423695B1
(en)
*
|
1998-01-13 |
2002-07-23 |
Ribapharm, Inc. |
Cytokine related treatments of disease
|
|
WO2000057907A2
(en)
*
|
1999-03-26 |
2000-10-05 |
Walter Reed Army Institute Of Research |
Multivalent dengue virus vaccine
|
|
AU8038400A
(en)
*
|
1999-09-09 |
2001-04-10 |
Zymetx, Inc. |
Method of treatment of influenza
|
|
AU7938900A
(en)
*
|
1999-10-27 |
2001-05-08 |
Cytos Biotechnology Ag |
Method for creating divergent populations of nucleic acid molecules and proteins
|
|
US7638496B2
(en)
|
2000-02-15 |
2009-12-29 |
Valeant Pharmaceuticals North America |
Nucleoside analogs with carboxamidine modified monocyclic base
|
|
KR20030005197A
(ko)
|
2000-02-18 |
2003-01-17 |
샤이어 바이오켐 인코포레이티드 |
뉴클레오시드유도체를 이용한 플라비바이러스 감염의 치료또는 예방 방법
|
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
CA2410579C
(en)
*
|
2000-05-26 |
2010-04-20 |
Jean-Pierre Sommadossi |
Methods and compositions for treating flaviviruses and pestiviruses
|
|
KR20090089922A
(ko)
*
|
2000-10-18 |
2009-08-24 |
파마셋 인코포레이티드 |
바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
|
|
SI1355916T1
(sl)
*
|
2001-01-22 |
2007-04-30 |
Merck & Co Inc |
Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze
|
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
WO2002069903A2
(en)
*
|
2001-03-06 |
2002-09-12 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
AU2002326736B2
(en)
*
|
2001-08-24 |
2007-08-02 |
Koronis Pharmaceuticals, Inc. |
Mutagenic nucleoside analogs for the treatment of viral disease
|
|
JP2005536440A
(ja)
*
|
2001-09-28 |
2005-12-02 |
イデニクス（ケイマン）リミテツド |
４’位が修飾されたヌクレオシドを使用するフラビウイルスおよびペスチウイルスの治療のための方法および組成物
|
|
US7049303B2
(en)
*
|
2001-11-07 |
2006-05-23 |
Medical Research Council |
Inhibition of viruses
|
|
US20040138170A1
(en)
*
|
2002-03-06 |
2004-07-15 |
Montgomery John A. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
CN1678326A
(zh)
*
|
2002-06-28 |
2005-10-05 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2'－c－甲基－3'－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
CN101172993A
(zh)
*
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
DE60326961D1
(de)
|
2002-07-26 |
2009-05-14 |
Novartis Vaccines & Diagnostic |
Modifizierte kleine irns moleküle und methoden zu deren anwendung
|
|
JP2006519753A
(ja)
*
|
2002-11-15 |
2006-08-31 |
イデニクス（ケイマン）リミテツド |
２’−分枝ヌクレオシドおよびフラビウイルス科ウイルス突然変異
|
|
MXPA05006230A
(es)
*
|
2002-12-12 |
2005-09-20 |
Idenix Cayman Ltd |
Proceso para la produccion de nucleosidos ramificados-2'.
|
|
CA2529311A1
(en)
*
|
2003-03-28 |
2004-10-07 |
Pharmasset, Inc. |
Compounds for the treatment of flaviviridae infections
|
|
WO2005018330A1
(en)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
|
US20070042352A1
(en)
*
|
2003-08-18 |
2007-02-22 |
Dawn Patricia Wooley |
Retroviral vector and cell-based assay for measuring the mutations rate of retroviruses employing same
|
|
JP2008532950A
(ja)
*
|
2005-03-08 |
2008-08-21 |
バイオタ サイエンティフィック マネージメント ピーティーワイ リミテッド |
治療薬としての二環式ヌクレオシドおよび二環式ヌクレオチド
|
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
|
US7572921B2
(en)
*
|
2005-04-05 |
2009-08-11 |
Boehringer Ingelheim International Gmbh |
Substituted benzylimidazoles useful for the treatment of inflammatory diseases
|
|
EP1976382B1
(en)
*
|
2005-12-23 |
2013-04-24 |
IDENIX Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
|
EP1859690A1
(en)
|
2006-05-26 |
2007-11-28 |
Health Concern B.V. |
Premix for cholesterol lowering food products
|
|
WO2009043096A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Arana Therapeutics (Vic) Pty Ltd |
Improved method for mutagenesis
|
|
BRPI0819831A2
(pt)
*
|
2007-11-29 |
2019-09-24 |
Boehringer Ingelheim Int |
derivados de amidas de áciodo 6,7-diidro-5h-imidazo[1,2-a]imidazol-3-carboxílico
|
|
JP4621926B2
(ja)
*
|
2008-07-24 |
2011-02-02 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸、核酸プローブ、マルチラベル化核酸プローブ、マルチラベル化核酸プローブの製造方法および標的核酸の検出方法
|
|
JP5146785B2
(ja)
*
|
2008-07-24 |
2013-02-20 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸誘導体
|
|
WO2010108140A1
(en)
*
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Substituted nucleoside and nucleotide analogs
|
|
BRPI1012581A2
(pt)
|
2009-06-02 |
2016-03-29 |
Boehringer Ingelheim Int |
derivados de amidas de ácido 6, 7-di-hidro-5h-imidazol[1,2-a]imidazol-3-carboxílico
|
|
EP2445914B1
(en)
|
2009-06-02 |
2015-07-22 |
Boehringer Ingelheim International GmbH |
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
|
|
JP5704481B2
(ja)
*
|
2010-01-22 |
2015-04-22 |
国立大学法人九州大学 |
核酸検出用キット
|
|
CN105061534A
(zh)
|
2010-09-22 |
2015-11-18 |
艾丽奥斯生物制药有限公司 |
取代的核苷酸类似物
|
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
EP2696679B1
(en)
|
2011-04-13 |
2017-08-02 |
Merck Sharp & Dohme Corp. |
2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
PH12013502141A1
(en)
|
2011-04-13 |
2014-01-06 |
Merck Sharp & Dohme |
2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
US9408863B2
(en)
|
2011-07-13 |
2016-08-09 |
Merck Sharp & Dohme Corp. |
5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
|
|
WO2013009735A1
(en)
|
2011-07-13 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
HK1203075A1
(en)
|
2011-12-22 |
2015-10-16 |
艾丽奥斯生物制药有限公司 |
Substituted phosphorothioate nucleotide analogs
|
|
EP2828277A1
(en)
|
2012-03-21 |
2015-01-28 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
WO2015167616A1
(en)
*
|
2014-05-02 |
2015-11-05 |
Nitor Therapeutics |
Guanosine as an immunepotentiator mediated through toll receptors
|
|
US12227769B2
(en)
|
2018-10-19 |
2025-02-18 |
The University Of Chicago |
Methods and compositions for treating negative-sense single-stranded RNA virus
|